Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Elanco Animal Health Incorporated    ELAN

ELANCO ANIMAL HEALTH INCORPORATED

(ELAN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Elanco Animal Health Incorporated : Gets Second Request From FTC on Bayer Deal

share with twitter share with LinkedIn share with facebook
share via e-mail
0
12/09/2019 | 06:31pm EST

By Stephen Nakrosis

Elanco Animal Health Inc. (ELAN) said it received a second request for information from the U.S. Federal Trade Commission regarding its planned acquisition of Bayer AG's animal health business.

In August, the two companies announced a deal that will see Elanco acquire the unit in a cash-and-stock deal valued at $7.6 billion. At the time, the companies said the transaction was expected to close by the middle of next year.

Elanco said Monday, "The request was anticipated as part of the regulatory process under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and the review continues to progress as expected."

--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

Stocks mentioned in the article
ChangeLast1st jan.
BAYER AG 0.66% 75.25 Delayed Quote.3.35%
ELANCO ANIMAL HEALTH INCORPORATED -1.99% 30 Delayed Quote.1.87%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ELANCO ANIMAL HEALTH INCOR
01/17ELANCO ANIMAL HEALTH INC : Entry into a Material Definitive Agreement, Financial..
AQ
01/13ELANCO ANIMAL HEALTH INCORPORATED : Signs Agreement with PetIQ to Divest Capstar..
BU
01/10ELANCO ANIMAL HEALTH INC : Results of Operations and Financial Condition, Financ..
AQ
01/10ELANCO ANIMAL HEALTH INCORPORATED : Announces 2020 Financial Guidance
BU
01/08ELANCO ANIMAL HEALTH INCORPORATED : Confirms Date for 2020 Financial Guidance An..
BU
01/06Elanco to Sell Osurnia as it Seeks Regulatory Blessing for Bayer Deal
DJ
01/06ELANCO ANIMAL HEALTH INCORPORATED : Signs Agreement with Dechra to Divest Osurni..
BU
01/03ELANCO ANIMAL HEALTH INCORPORATED : to Present at the 38th Annual J.P. Morgan He..
BU
2019ELANCO ANIMAL HEALTH INCORPORATED :  Elanco Sells Victoria, PEI, Canada R&D Faci..
BU
2019ELANCO ANIMAL HEALTH INC : Entry into a Material Definitive Agreement, Financial..
AQ
More news
Financials (USD)
Sales 2019 3 074 M
EBIT 2019 582 M
Net income 2019 80,8 M
Debt 2019 1 881 M
Yield 2019 0,04%
P/E ratio 2019 154x
P/E ratio 2020 207x
EV / Sales2019 4,25x
EV / Sales2020 4,12x
Capitalization 11 190 M
Chart ELANCO ANIMAL HEALTH INCORPORATED
Duration : Period :
Elanco Animal Health Incorporated Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ELANCO ANIMAL HEALTH INCOR
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 33,63  $
Last Close Price 30,00  $
Spread / Highest target 26,7%
Spread / Average Target 12,1%
Spread / Lowest Target 0,00%
EPS Revisions
Managers
NameTitle
Jeffrey N. Simmons President, Chief Executive Officer & Director
R. David Hoover Independent Chairman
Todd S. Young Chief Financial Officer & Executive Vice President
Christopher Keeley Chief Information Officer & Vice President
Shabbir Simjee Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ELANCO ANIMAL HEALTH INCORPORATED1.87%11 190
ZOETIS5.90%66 758
DECHRA PHARMACEUTICALS PLC-2.28%3 786
JINYU BIO-TECHNOLOGY CO., LTD.49.34%3 410
VIRBAC-5.29%2 095
PHIBRO ANIMAL HEALTH CORPORATION3.89%1 044